Source link : https://newshealth.biz/health-news/topical-tx-effective-in-children-with-more-extensive-ad/
TOPLINE: Treatment with ruxolitinib cream resulted in significant disease control over 52 weeks in a subset of children with moderate/more extensive atopic dermatitis (AD) in a randomized trial that evaluated both 0.75% and 1.5% strengths of the topical JAK inhibitor. METHODOLOGY: The TRuE-AD3 study evaluated long-term disease control and safety of ruxolitinib cream in children […]
The post Topical Tx Effective in Children With More Extensive AD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-08 04:24:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8